Floatz logo

Vormatrogine

Epilepsy, Tonic-Clonic

Praxis Precision MedicinesPhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Epilepsy, Tonic-Clonic cohort.

Asset / SponsorPhaseRating
LAMOTRIGINE
GlaxoSmithKline
Phase 4BBB
MIDAZOLAM
Pakistan Air Force (PAF) Hospital Islamabad
Phase 4BB
Keppra
Emory University
Phase 4BB
Topamax
GlaxoSmithKline
Phase 3BB
Pregabalin
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 3BB

View all 12 →

Same molecule, other indications

Vormatrogine is also rated in:

focal epilepsyDormant
B
Indicative ·
60 / 100
View asset →
generalized epilepsyDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →